2-(2-Fluoro-5-(methylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 1g

1-Ethyl-4-[(4-methylphenyl)ethynyl]benzene>98.0%(GC)5g

3-Chloro-5-(trifluoromethyl)pyridine-2-thiol, 85.0%, 250mg

N-Benzyl-N-cyclopropylcyclopropanamine, 97%, 500mg

2-PHENYL-9H-CARBAZOLE, 97.0%, 25g

N-(2,4-DIBROMO-6-CYANOPHENYL)ACETAMIDE, 90.0%, 250mg

Methyl 6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxylate, 98%, 1g

3-(4-methoxyphenyl)isoxazol-5-amine, 95.0%, 1g

Monomethyl Maleate>90.0%(GC)500mL

1-(Tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-amine, 97.0%, 100mg

Butanedioic acid, compd. with 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide (1:1), 98%, 5g

(1-Phenyl-ethyl)thiourea, 95%, 1g

4-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 95.0%, 100mg